OOIR: Observatory of International Research

Papers

(The TQCC of Pharmacogenomics is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Precision Medicine in Interventional Cardiology: Implications for Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention	25
Assessing COVID-19 Susceptibility Through Analysis of the Genetic and Epigenetic Diversity of ACE2-Mediated SARS-CoV-2 Entry	25
The Inclusion of Health Data Standards in the Implementation of Pharmacogenomics Systems: A Scoping Review	24
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program	22
PGxKnow: A Pharmacogenomics Educational Hololens Application of Augmented Reality and Artificial Intelligence	20
Pharmacogenomic Testing to Support Prescribing in Primary Care: a Structured Review of Implementation Models	20
Potential of Whole-Genome Sequencing-Based Pharmacogenetic Profiling	20
Strategies and Settings of Clinical Pharmacogenetic Implementation: a Scoping Review of Pharmacogenetics Programs	19
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary	18
Pharmacogenomics of Oxycodone: A Narrative Literature Review	17
Pharmacogenomics in the Uk National Health Service: Opportunities and Challenges	16
The pharmacogenetics of treatment with olanzapine	15
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role	15
Genetic Susceptibilities and Prediction Modeling of Carbamazepine and Allopurinol-Induced Severe Cutaneous Adverse Reactions in Vietnamese	15
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing	14
Pharmacogenomics Education, Research and Clinical Implementation in the State of Minnesota	14
Understanding the Barriers and Enablers of Pharmacogenomic Testing in Primary Care: A Qualitative Systematic Review with Meta-Aggregation Synthesis	14
Providers’ Perspectives on the Clinical Utility of Pharmacogenomic Testing in Pediatric Patients	14
lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis	14
Therapy Response Prediction in Major Depressive Disorder: Current and Novel Genomic Markers Influencing Pharmacokinetics and Pharmacodynamics	12
Substrate Specificity of CYP2D6 Genetic Variants	12
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease	12
Evaluating the Current Level of Pharmacists’ Pharmacogenomics Knowledge and its Impact on Pharmacogenomics Implementation	11
Effect of UGT Polymorphisms on Pharmacokinetics and Adverse Reactions of Mycophenolic Acid in Kidney Transplant Patients	11
Developing a Gene Panel for Pharmacoresistant Epilepsy: A Review of Epilepsy Pharmacogenetics	11

The Effect of CYP2C19 Gene Polymorphism on the Eradication Rate of Helicobacter Pylori by Proton Pump Inhibitors-ContAining Regimens in As	10
The Need to Shift Pharmacogenetic Research from Candidate Gene to Genome-Wide Association Studies	10
The Effects of Sex on Pharmacogenetically Guided Drug Treatment	10
Resolving Discordant CYP2D6 Genotyping Results in Thai Subjects: Platform Limitations and Novel Haplotypes	10
Exploring Pharmacogenetic Variants for Predicting Response to Anti-TNF Therapy in Autoimmune Diseases: a Meta-Analysis	10
NAMPT Single-Nucleotide Polymorphism rs1319501 and Visfatin/NAMPT Affect Nitric Oxide Formation, sFlt-1 and Antihypertensive Therapy Response in Preeclampsia	10
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites	10
Impact of Variants in Atp-Binding Cassette Transporters on Breast Cancer Treatment	9
miRNAs as Potential Biomarkers of Treatment Outcome in Rheumatoid Arthritis and Ankylosing Spondylitis	9
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms	9
Pharmacogenetics of Inflammatory Bowel Disease	9
The Frequency of Rs2231142 in ABCG2 among Asian Subgroups: Implications for Personalized Rosuvastatin Dosing	9
Patients Carrying DPYD Variant Alleles have Increased Risk of Severe Toxicity and Related Treatment Modifications During Fluoropyrimidine Chemotherapy	8
HLA-DRB1 *16:02 is Associated with PEG-Asparaginase Hypersensitivity	8
Polymorphisms in the CYP3A5 Gene Significantly Affect the Pharmacokinetics of Sirolimus After Kidney Transplantation	8
Nonresponse to High-Dose Bupropion for Depression in a Patient Carrying CYP2B6 6 and CYP2C19* *17 variants: a case report	8
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse Events	8
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing	8
Effects of SLCO1B1 on Elimination and Toxicities of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia	8
Gender-Dependent Association of Tyms -TSER Polymorphism With 5-Fluorouracil or Capecitabine-Based Chemotherapy Toxicity	8
Malignant Hyperthermia Susceptibility: Utilization of Genetic Results in an Electronic Medical Record to Increase Safety	8
Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty	8
Is Olaparib Cost Effective in Metastatic Castration-Resistant Prostate Cancer Patients with at Least one Favorable Gene Mutation in BRCA1 , BRCA2	7
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice	7
Adolescent Perceptions of Pharmacogenetic Testing	7
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy	7
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells	7
Synthesis of Major Pharmacogenomics Pretest Counseling Themes: A Multisite Comparison	7
CYP2D6 Pharmacogenetics and Risperidone: Reflections after 25 Years of Research	7
Resistance to Platinum-Based Cancer Drugs: a Special Focus on Epigenetic Mechanisms	7
Patients’ Perspectives of a Pharmacist-Provided Clinical Pharmacogenomics Service	7
Pharmacogenetics of Clopidogrel and Warfarin in the Treatment of Cardiovascular Diseases: An Overview of Reviews	7
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population	7
Pharmacogenetic Loci for Rosuvastatin are Associated with Intima-Media Thickness Change and Coronary Artery Disease Risk	7
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?	7
Personal Genotyping and Student Outcomes in Genetic and Pharmacogenetic Teaching: a Systematic Review and Meta-Analysis	6
Pharmacogenetic Differentiation Across Latin America	6
Clinical Pharmacogenomics Implementation In Thailand: A Dream Come True	6
Methods for Actionable Gene Fusion Detection in Lung Cancer: Now and in the Future	6
Genetic Variability of CYP2D6, CYP3A4 and CYP3A5 Among the Egyptian Population	6
HLA-A24:07* as a Potential Biomarker for Carbamazepine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Filipino Patients	6
A Meta-Analysis of Effects of Cyp2C9 and Cyp2C19 Polymorphisms on Phenytoin Pharmacokinetic Parameters	6
Novel Associations Between Cyp2B6 Polymorphisms, Perioperative Methadone Metabolism and Clinical Outcomes in Children	6
Genetic Characterization of N -acetyltransferase 2 variants in Acquired Multidrug-Resistant Tuberculosis in Indonesia	6
The Association Between HLA-B15:02* and Phenytoin-Induced Severe Cutaneous Adverse Reactions: A Meta-Analysis	6
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate	6
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?	6
Pharmacogenomic Landscape of Covid-19 Therapies From Indian Population Genomes	6
Efficacy and Safety of Opioid Therapy Guided by Pharmacogenetics: A Systematic Review	6
Pharmacogenomics in Clinical Practice to Prevent Risperidone-Induced Hyperprolactinemia in Autism Spectrum Disorder	6

Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management	6
Pharmacogenetic Testing in Psychiatry and Neurology: an Overview of Reviews	6
Genome-Wide Association Study of Liver Enzyme Elevation in Rheumatoid Arthritis Patients Starting Methotrexate	6
Predictive Association of ABCB1 C3435T Genetic Polymorphism with the Efficacy or Safety of Lopinavir and Ritonavir in COVID-19 Patients	6
Allopurinol-Induced Severe Cutaneous Adverse Reactions in Vietnamese: The Role of HLA Alleles and Other Risk Factors	5
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”	5
Engaging Pharmacogenomics in Pain Management and Opioid Selection	5
Case Report: Severe Toxicity in an African–American Patient Receiving FOLFOX Carrying Uncommon Allelic Variants in DPYD	5
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?	5
The Pharmacogenomics of Selective Serotonin Reuptake Inhibitors	5
Pharmacogenomics Education and Perceptions: is there A Gap Between Internal Medicine Resident and Attending Physicians?	5
Influence of CYP2D6 Gene Polymorphisms on the Pharmacokinetics of Aripiprazole in Healthy Chinese Subjects	5
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants	5
Pharmacogenetic Evaluation of 6-Mercaptopurine-Mediated Toxicity in Pediatric Acute Lymphoblastic Leukemia Patients from a South Indian Population	5
Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race	5
Impact of the PEAR 1 Polymorphism on Clinical Outcomes in Chinese Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Interventio	5
Pharmacogenomics and Prescription Opioid Use	5
Unraveling Heterogeneity of the Clinical Pharmacogenomic Guidelines in Oncology Practice Among Major Regulatory Bodies	5
Role of miRNA Gene Variants in the Susceptibility and Pharmacogenetics of Colorectal Cancer	5
Integrating Pharmacogenetic Testing Via Medication Therapy Management in an Outpatient Family Medicine Clinic	5